1 not yet recruiting. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
Follow EGFR-TKI: new trials by email Literature Review of EGFR-TKI trials Research Report on EGFR-TKI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs Ivonescimab combined with chemotherapy - NSCLC, Chemotherapy | Not applicable | Not yet recruiting | Jiangsu Province Nanjing Brain Hospital | 36 | 2025-01-01 | 2025-01-09 |
Central Nervous System Neoplasms (1) · Meningeal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1)
Drug Therapy (1)
Jiangsu Province Nanjing Brain Hospital (1)
PMID 25601652, PMID 37879536, PMID 38642937, PMID 38820549, PMID 39073550, PMID 39661345, PMID 39661367, PMID 39661384